Stockreport

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF - 2024 net product sales of approximately $336 million exceeds upper end of guidance range; preliminary and unaudited estimate- 2025 expected global net product sales of [Read more]